Trials that use: Logistic regression
New to this method? Read the tutorial →
4,487 results
- A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Explore the Tolerability, Safety and Efficacy of Paliperidone Extended Release in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate…
- A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and…
- A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing’s Sarcoma: Complete Statistical AnalysisIndependent statistical analysis of A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals: Complete Statistical AnalysisIndependent statistical analysis of A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A-PREDICTIndependent statistical analysis of A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A-TREATIndependent statistical analysis of American Trial Using Tranexamic Acid in Thrombocytopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02578901).
- AAA CEUSIndependent statistical analysis of Evaluation of Contrast-Enhanced Ultrasound to Detect Endoleaks After Endovascular Aortic Aneurysm Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AAINTVAPIndependent statistical analysis of Aerosolized Antibiotics in the Treatment of Ventilator Associated Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02478710).
- Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu’s Arteritis: Complete Statistical AnalysisIndependent statistical analysis of Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Abatacept in Treating Adults With Mild Relapsing Wegener’s Granulomatosis: Complete Statistical AnalysisIndependent statistical analysis of Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00468208).
- ABATEIndependent statistical analysis of Active Bathing to Eliminate Infection (ABATE Infection) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02063867).
- ABCIndependent statistical analysis of Arrythmia Burden in Cardiac Contractility Modulation (CCM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05704426).
- ABC Mental Health: A Behavioral Study of K-12 Teachers and School Staff: Complete Statistical AnalysisIndependent statistical analysis of ABC Mental Health: A Behavioral Study of K-12 Teachers and School Staff: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ABD- BINDERIndependent statistical analysis of Abdominal Binder to Reduce Pain and Seroma Formation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01673568).
- ABEMA Alone or in COMBO With MK-6482: Complete Statistical AnalysisIndependent statistical analysis of ABEMA Alone or in COMBO With MK-6482: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04627064).
- ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis: Complete Statistical AnalysisIndependent statistical analysis of Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size…
- Ablate-NCSIndependent statistical analysis of Cardioneuroablation for Neurocardiogenic Syncope: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02009982).
- ABLATORIndependent statistical analysis of ABLATOR Ablation Observational Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02344173).
- Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI: Complete Statistical AnalysisIndependent statistical analysis of Abnormal Ventilatory Response to Carbon Dioxide: a Potential Biomarker for Seizure Induced Respiratory Depression & Modification by SSRI: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Abraxane in Combination With Carboplatin, Erbitux and IMRT for Locally Advanced Squamous Cancer of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ABSORB EXTENDIndependent statistical analysis of ABSORB EXTEND Clinical Investigation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01023789).
- Absorb IV Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Absorb IV Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02173379).
- AC105Independent statistical analysis of AC105 in Patients With Acute Traumatic Spinal Cord Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01750684).
- Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04058249).
- Accelerated Tooth Movement With AcceleDent® and Aligners – a Pilot Project: Complete Statistical AnalysisIndependent statistical analysis of Accelerated Tooth Movement With AcceleDent® and Aligners - a Pilot Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Accent CardiacIndependent statistical analysis of Accent Cardiac MRI Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02041702).
- ACCESS IIndependent statistical analysis of Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ACCOASTIndependent statistical analysis of A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Accupressure of P6 to Reduce Nausea During Cesarean Section: Complete Statistical AnalysisIndependent statistical analysis of Accupressure of P6 to Reduce Nausea During Cesarean Section: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04799587).
- Accuracy of Self-estimation of Blood Alcohol Concentration Compared to Object Values: Complete Statistical AnalysisIndependent statistical analysis of Accuracy of Self-estimation of Blood Alcohol Concentration Compared to Object Values: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Accuracy of the New Barrett TAL Formula With the Argos Measurements: A Multicenter Prospective Study: Complete Statistical AnalysisIndependent statistical analysis of Accuracy of the New Barrett TAL Formula With the Argos Measurements: A Multicenter Prospective Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ACCURATEIndependent statistical analysis of A Safety and Effectiveness Trial of Spinal Cord Stimulation of the Dorsal Root Ganglion for Chronic Lower Limb Pain: primary endpoint results, effect estimate with confidence interval, sample-size…
- ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients: Complete Statistical AnalysisIndependent statistical analysis of ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01867047).
- Acetaminophen Before Vaccines for Infants Study (AVIS): Complete Statistical AnalysisIndependent statistical analysis of Acetaminophen Before Vaccines for Infants Study (AVIS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00325819).
- Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm: Complete Statistical AnalysisIndependent statistical analysis of Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00585559).
- ACHIEVEIndependent statistical analysis of Albumin for Intracerebral Hemorrhage Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00990509).
- ACHIEVE IComplete statistical analysis of ACHIEVE I, a randomized, double-blind phase 3 trial of oral ubrogepant for the acute treatment of migraine with or without aura, including endpoint definitions, logistic regression, odds ratios,…
- AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study: Complete Statistical AnalysisIndependent statistical analysis of AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04126187).
- ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises: Complete Statistical AnalysisIndependent statistical analysis of ACT for Life: a Brief Intervention for Maximizing Recovery After Suicidal Crises: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ACT IIndependent statistical analysis of Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I): primary endpoint results,…
- ACTH Gel Therapy in Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of ACTH Gel Therapy in Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02030028).
- ACTHARIndependent statistical analysis of Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses: primary endpoint results, effect estimate with confidence interval, sample-size…
- ACTIV-6: COVID-19 Study of Repurposed Medications: Complete Statistical AnalysisIndependent statistical analysis of ACTIV-6: COVID-19 Study of Repurposed Medications: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04885530).